Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000354887 | SCV000341712 | uncertain significance | not provided | 2016-04-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000551417 | SCV000630824 | uncertain significance | Walker-Warburg congenital muscular dystrophy | 2022-07-12 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 285 of the FKTN protein (p.Ala285Val). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with FKTN-related conditions. ClinVar contains an entry for this variant (Variation ID: 287804). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV000354887 | SCV003832689 | uncertain significance | not provided | 2019-06-10 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000551417 | SCV002079603 | uncertain significance | Walker-Warburg congenital muscular dystrophy | 2020-02-26 | no assertion criteria provided | clinical testing |